Basecare Biotechnology

Basecare Medical is a leading Chinese biotechnology company specializing in reproductive health and genetic testing. The company is the first to receive NMPA approval for a Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit in China, establishing a dominant position in the domestic market. Its comprehensive portfolio covers the entire reproductive cycle, including pre-implantation, prenatal, and postnatal stages, utilizing advanced next-generation sequencing (NGS) technologies. Basecare also develops automated laboratory equipment and cryopreservation solutions to support assisted reproductive technology (ART) clinics. The company is headquartered in Suzhou and is listed on the Hong Kong Stock Exchange.